# Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment

> **NCT05985551** · — · ACTIVE_NOT_RECRUITING · sponsor: **Uppsala University** · enrollment: 114 (estimated)

## Conditions studied

- Breast Cancer
- Chemotherapy Effect
- Sentinel Lymph Node

## Interventions

- **OTHER:** SLND or TAD by the magnetic technique (SPIO)

## Key facts

- **NCT ID:** NCT05985551
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-01-01
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-10-30
- **Target enrollment:** 114 (ESTIMATED)
- **Last updated:** 2024-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05985551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05985551, "Delayed SLND for Patients With Breast Cancer Undergoing Primary Systemic Treatment". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05985551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*